|
|
News Breaks
|
November 11, 2009
|
| 08:05 EDT |  | AIS |
| theflyonthewall.com: | Antares Pharma enters into license and asset purchase agreements | | Antares Pharma announced the simultaneous signing of a license and an asset purchase agreement with Ferring International Center S.A. Under the terms of the exclusive license agreement Ferring obtained rights to certain intellectual property relating to Antares’ proprietary transdermal gel delivery technology. Upon closing of the asset purchase agreement Ferring will purchase research equipment and assume responsibility for Antares’ leased development facility in Allschwil, Switzerland. A majority of the current employees at the facility will become employees of Ferring. Importantly, these agreements will have no impact on Antares’ current licenses, the transdermal clinical pipeline, or marketed products including Anturol LibiGel, Nestorone, and Elestrin. Financial terms of the agreements which consist of upfront payments and milestones were not disclosed. :theflyonthewall.com |
|
|
News For AIS From The Last 14 Days Check below for free stories on AIS the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 1, 2012
|
| 10:33 EDT |  | AIS |
| | 06:27 EDT | | AIS |
|
|
|
|
|
Subscribe for More Information